menu search

Ionis pharmaceuticals (ions) q4 earnings and revenues beat estimates

Ionis pharmaceuticals (IONS) delivered earnings and revenue surprises of 76.25% and 30.36%, respectivel...

February 24, 2022, 10:50 am

Oncotelic presenting at medinvest pharmaceutical and biotechnology investor conference

AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l...

February 24, 2022, 8:47 am

Oncotelic presenting at medinvest pharmaceutical and biotechnology investor conference

AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l...

February 24, 2022, 8:47 am

Oncotelic presenting at medinvest pharmaceutical and biotechnology investor conference

AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l...

February 24, 2022, 8:47 am

Hikma pharmaceuticals sales grow 9%, announces us$300mln share buyback

Hikma pharmaceuticals PLC (AIM:HIK, OTC:HKMPF) reported “solid growth” for 2021, with sales rising ...

February 24, 2022, 5:51 am

Hikma pharmaceuticals sales grow 9%, announces us$300mln share buyback

Hikma pharmaceuticals PLC (AIM:HIK, OTC:HKMPF) reported “solid growth” for 2021, with sales rising ...

February 24, 2022, 5:51 am

Hikma pharmaceuticals sales grow 9%, announces us$300mln share buyback

Hikma pharmaceuticals PLC (AIM:HIK, OTC:HKMPF) reported “solid growth” for 2021, with sales rising ...

February 24, 2022, 5:51 am

Vanda pharmaceuticals inc. (vnda) ceo mihael polymeropoulos on q4 2021 results - earnings call transcript

Vanda pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcri...

February 23, 2022, 10:18 pm

Vanda pharmaceuticals inc. (vnda) ceo mihael polymeropoulos on q4 2021 results - earnings call transcript

Vanda pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcri...

February 23, 2022, 10:18 pm

Vanda pharmaceuticals inc. (vnda) ceo mihael polymeropoulos on q4 2021 results - earnings call transcript

Vanda pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcri...

February 23, 2022, 10:18 pm

Biomarin pharmaceutical inc. (bmrn) ceo j.j. bienaime on q4 2021 results - earnings call transcript

BioMarin pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q4 2021 Results - Earnings Call Transcript...

February 23, 2022, 9:18 pm

Biomarin pharmaceutical inc. (bmrn) ceo j.j. bienaime on q4 2021 results - earnings call transcript

BioMarin pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q4 2021 Results - Earnings Call Transcript...

February 23, 2022, 9:18 pm

Biomarin pharmaceutical inc. (bmrn) ceo j.j. bienaime on q4 2021 results - earnings call transcript

BioMarin pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q4 2021 Results - Earnings Call Transcript...

February 23, 2022, 9:18 pm

Biomarin pharmaceutical (bmrn) q4 earnings and revenues top estimates

BioMarin (BMRN) delivered earnings and revenue surprises of 250% and 1.22%, respectively, for the quarter ended December 2021. Do the numbers hold clu...

February 23, 2022, 7:12 pm

Biomarin pharmaceutical (bmrn) q4 earnings and revenues top estimates

BioMarin (BMRN) delivered earnings and revenue surprises of 250% and 1.22%, respectively, for the quarter ended December 2021. Do the numbers hold clu...

February 23, 2022, 7:12 pm

Biomarin pharmaceutical (bmrn) q4 earnings and revenues top estimates

BioMarin (BMRN) delivered earnings and revenue surprises of 250% and 1.22%, respectively, for the quarter ended December 2021. Do the numbers hold clu...

February 23, 2022, 7:12 pm

Why biocryst pharmaceuticals stock slid today

The biotech's immediate future doesn't look profitable....

February 23, 2022, 6:30 pm

Why biocryst pharmaceuticals stock slid today

The biotech's immediate future doesn't look profitable....

February 23, 2022, 6:30 pm

Why biocryst pharmaceuticals stock slid today

The biotech's immediate future doesn't look profitable....

February 23, 2022, 6:30 pm

Moderna's story is what's the encore to covid-19, says bank of america's geoff meacham

Geoff Meacham, Bank of America senior pharmaceutical analyst, joins 'Power Lunch' to preview Moderna's ...

February 23, 2022, 5:09 pm


Search within

Pages Search Results: